U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07853040) titled 'A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Hepatic Impairment' on Sept. 25.
Brief Summary: This study is conducted to evaluate the pharmacokinetics and safety of INCB161734 in participants with hepatic impairment.
Study Start Date: Oct. 13
Study Type: INTERVENTIONAL
Condition:
Hepatic Insufficiency
Liver Diseases
Intervention:
DRUG: INCB161734
single dose administered orally
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Incyte Corporation
Published by HT Digital Content Services with permission from Health Daily Digest....